JONES FINANCIAL COMPANIES LLLP

Position in NBIX — Neurocrine Biosciences Inc

CIK 815917 DES PERES, MO

Back to NBIX Full portfolio

Position in NBIX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,049,911

+$2,933,611 QoQ

Shares Held

23,151

+2723.3% QoQ

Ownership

0.023%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

10 quarters on record

Voting authority Sole 98.97628612154983.ToString("F0")% Shared 0.ToString("F0")% None 1.023713878450175.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

JONES FINANCIAL COMPANIES LLLP holds $151,859,373 across 48 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HLN	Haleon plc	9,086,528	$90,956,145
2	ZTS	Zoetis Inc.	179,646	$21,235,953
3	PBH	Prestige Consumer Healthcare Inc.	250,151	$14,826,449
4	TEVA	Teva Pharmaceutical Industries Ltd	321,219	$9,675,116
5	ESPR	Esperion Therapeutics, Inc.	2,135,741	$5,851,930
6	NBIX	Neurocrine Biosciences Inc This page	23,151	$3,049,911
7	UTHR	UNITED THERAPEUTICS Corp	2,960	$1,755,220
8	AMRX	Amneal Pharmaceuticals, Inc.	54,322	$675,222

All Filings in NBIX

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,049,911	23,151	+2723.3%	Shares	Sole	2026-05-15
2025-12-31	$116,300	820	+16.5%	Shares	Sole	2026-02-17
2025-09-30	$98,826	704	+17.3%	Shares	Sole	2025-11-04
2025-06-30	$75,413	600	+72.9%	Shares	Sole	2025-08-13
2025-03-31	$38,378	347	+86.6%	Shares	Sole	2025-05-28
2024-12-31	$25,389	186	+42.0%	Shares	Sole	2025-02-06
2024-09-30	$15,093	131	+445.8%	Shares	Sole	2024-11-12
2024-06-30	$3,304	24	+84.6%	Shares	Sole	2024-08-14
2022-06-30	$1,267	13	+116.7%	Shares	Sole	2022-08-08
2021-03-31	$583	6	—	Shares	Sole	2021-04-30
No filing history on record for this holder in this stock.